spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

ACM Global Central Lab Expands to New Facility

US Specimen Processing Department moves to cater for growth in clinical trials

ACM Global Central Laboratory, the global central lab that continually defines the customer-service standard with its flexible approach, today announced the specimen processing department at its US site, located in Rochester, NY, has completed a successful move into a new 7,200 square feet facility. The specimen processing department, responsible for opening packages containing specimens shipped to ACM for testing, sample Quality Control and specimen accessioning, has expanded into space next door to the main site to allow for the increase in workload and capacity.

The move to the new facility was prompted by the very strong growth in the demand for ACM’s clinical trials support services. The specimen processing department outgrew the space available in ACM’s headquarters. There are a total of 18 workstations available for specimen processing in the new space. Eleven new workstations were set up during construction and the final seven workstations were moved from 160 Elmgrove Park to the new building on January 14, 2011. The new facility can also hold over 20 freezers, including a liquid nitrogen tank available for specimen storage.

Renay Moore heads the department as Director of Clinical Trials Support Operations. Renay has been with ACM for over six years and was recently promoted from her role as a Senior Project Manager.

“We are excited to announce the expansion of the specimen processing department here in Rochester”, said Renay Moore. “This project started back in July 2010 and it’s thanks to the hardwork and support of our contractors and employees that the re-location has been carried out in such a timely manner.”

About ACM Global Central Laboratory
ACM Global Central Laboratory offers a flexible approach and a focus on precision to keep clinical research studies on schedule. ACM’s operations extend to more than 60 countries with all tests conducted and managed from central lab facilities with seamless data management providing a single database. The organization performs 13 million tests each year, featuring more than 1,500 individual tests spanning all medical disciplines, including pathology, microbiology, flow cytometry and pharmacogenomics. Combining comprehensive safety, efficacy and pathology testing from a single lab ensures clients receive consistent, analyzable test results with faster and cleaner reporting. For more information, visit www.acmgloballab.com.

 
 
Print this page
Send to a friend
   
spacer
News and Press Releases

Charles River Laboratories Announces Extended Relationship with The Michael J. Fox Foundation

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) today announced an extension of its long-standing collaboration with The Michael J. Fox Foundation for Parkinson’s Research (MJFF), a leading organization working to support the diagnosis and treatment of Parkinson’s disease (PD). Since 2011, Charles River and MJFF have worked together to accelerate the discovery of therapies for PD. This latest extension includes grants from MJFF to support two projects:
More info >>


White Papers

Bringing more control to temperature-sensitive logistics

UPS Supply Chain Solutions

By 2016, world sales of cold-chain drugs and biologics such as vaccines and blood plasma products will near $240 billion1. The increase has led to a surge in discussion about how to protect these products throughout the transportation logistics cycle. Industry experts are recommending that the term “cold chain” be eliminated from rules, guidance and best-practice documents. “Cold chain” now includes a broader spectrum of temperature ranges, such as controlled room temperature (CRT). This white paper focuses on the initial steps required to establish a temperature-sensitive supply chain.
More info >>

Industry Events

BioPharm America 2018

5-6 September 2018, Hynes Convention Center

BioPharm America™ is a unique partnering event that forms the nexus of discovery and realization. Startup companies, established biotech and entrepreneurs from academia attend in search of finance, pharma and development partners. The event format highlights innovation and promotes new business relationships by bringing dealmakers from the life science ecosystem together to engage and de-risk the enormous task of drug development.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement